Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
larger decrease » marked decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
49321
Image_2_Suicide risk among female breast cancer survivors: A population–based study.tif
Published 2022“…Female breast cancer survivors had a higher risk of suicide than the general population (SMR = 1.19; 95% CI (1.08–1.31)). …”
-
49322
-
49323
Impact of body mass index on growth hormone stimulation tests in children and adolescents: a systematic review and meta-analysis
Published 2021“…Pubertal status, presence of syndromic obesity, mean age, and mean BMI SDS did not moderate the pooled <i>r</i> (all <i>p</i> > 0.05). Individual participant data analysis revealed a beta of −0.123 (95% CI −0.160 to −0.086, <i>p</i> < 0.0001), i.e. per one-point increase in BMI SDS, peak GH decreases by 11.6% (95% CI 8.3–14.8%). …”
-
49324
DataSheet1_Ambient Air Quality Standards and Policies in Eastern Mediterranean Countries: A Review.docx
Published 2023“…We estimated that the reduction of annual mean PM<sub>2.5</sub> exposure level to the AQG level (5 μg m<sup>−3</sup>) would be associated with a decrease of all natural-cause mortality in adults (age 30+) by 16.9%–42.1% in various EMR countries. …”
-
49325
Operons with an upstream FNR ChIP-seq peak and a FNR-dependent change in expression under GMM.
Published 2013“…Each operon was determined to have a significant (>2 fold) increase (+), decrease (−) and no change (o) in WT −O<sub>2</sub> relative to WT +O<sub>2</sub> (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003565#pgen.1003565.s018" target="_blank">Table S12</a>).…”
-
49326
UBKIs possess broad antiviral activity, are effective in primary cells, and impose a barrier against resistance development.
Published 2019“…The calculation of p-values revealed a significant decrease of log-transformed virus-titers in the regorafenib and sorafenib-treated groups relative to the DMSO control at the indicated time points: *: p-value ≤ 0.05. …”
-
49327
Gene set enrichment analysis revealed NF-κB signaling as a potential downstream regulator of Efp.
Published 2018“…(<b>D</b> and <b>E</b>) Decrease of <i>IL6ST</i> and <i>IL18</i> mRNA levels in siEfp #A-treated tumors <i>in vivo</i>. …”
-
49328
-
49329
-
49330
Removal of aggregates by chaperones rescue expression pattern of micoRNAs, p53 and RelA/NFkB.
Published 2011“…<p>(<b>A</b>) RT-PCR showing increase in p53 expression in ST<i>Hdh<sup>Q7</sup>/Hdh<sup>Q7</sup></i> cells co-transfected with 83Q DsRed and empty vector GFP-C1 (lane ii, n = 3, p = 0.028) and decrease in p53 expression in ST<i>Hdh<sup>Q7</sup>/Hdh<sup>Q7</sup></i> cells co-transfected with 83Q DsRed and Hsp70-GFP (lane iii, n = 3, p = 0.025) and 83Q DsRed and HYPK-GFP (lane iv, n = 3, p = 0.019) compared to control ST<i>Hdh<sup>Q7</sup>/Hdh<sup>Q7</sup></i> cells (lane i). …”
-
49331
H<sub>2</sub>BZmacropa-NCS: A Bifunctional Chelator for Actinium-225 Targeted Alpha Therapy
Published 2022“…Actinium-225 (<sup>225</sup>Ac) is one of the most promising radionuclides for targeted alpha therapy (TAT). With a half-life of 9.92 days and a decay chain that emits four high-energy α particles, <sup>225</sup>Ac is well-suited for TAT when conjugated to macromolecular targeting vectors that exhibit extended in vivo circulation times. …”
-
49332
H<sub>2</sub>BZmacropa-NCS: A Bifunctional Chelator for Actinium-225 Targeted Alpha Therapy
Published 2022“…Actinium-225 (<sup>225</sup>Ac) is one of the most promising radionuclides for targeted alpha therapy (TAT). With a half-life of 9.92 days and a decay chain that emits four high-energy α particles, <sup>225</sup>Ac is well-suited for TAT when conjugated to macromolecular targeting vectors that exhibit extended in vivo circulation times. …”
-
49333
Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
Published 2010“…</p><h3>Trial registration</h3><p><a href="http://www.ClinicalTrials.gov">www.ClinicalTrials.gov</a><a href="http://www.clinicaltrials.gov/ct2/results?…”
-
49334
H<sub>2</sub>BZmacropa-NCS: A Bifunctional Chelator for Actinium-225 Targeted Alpha Therapy
Published 2022“…Actinium-225 (<sup>225</sup>Ac) is one of the most promising radionuclides for targeted alpha therapy (TAT). With a half-life of 9.92 days and a decay chain that emits four high-energy α particles, <sup>225</sup>Ac is well-suited for TAT when conjugated to macromolecular targeting vectors that exhibit extended in vivo circulation times. …”
-
49335
<sup>68</sup>Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity
Published 2019“…Employing the fluorescent traits of Galmydar, live cell fluorescence imaging indicated a gradual decrease in uptake and retention of Galmydar within mitochondria of H9c2 cells following DOX-treatment, while indicating dose-dependent and time-dependent uptake profiles. …”
-
49336
A High Throughput Genetic Screen Identifies New Early Meiotic Recombination Functions in <em>Arabidopsis thaliana</em>
Published 2009“…A collection of 55,000 mutant lines was screened, and <em>spo11</em>-like mutations, characterised by a drastic decrease in chiasma formation at metaphase I associated with an absence of synapsis at prophase, were selected. …”
-
49337
-
49338
Data from population B analyzed for this report.
Published 2024“…In population A, when two parents were screened with the VMBDD compared to one, there was an average LI decrease of 0.03 (P<0.05). …”
-
49339
-
49340
Legend for supporting information S2–S5.
Published 2024“…In population A, when two parents were screened with the VMBDD compared to one, there was an average LI decrease of 0.03 (P<0.05). …”